treatment Archives - Page 2 of 10

Trump sparks new FDA concerns with praise of ‘miracle’ treatment

October 10, 2020

President Trump’s public praise for an experimental coronavirus antibody treatment is putting new pressure on the Food and Drug Administration (FDA) to quickly give emergency clearance to a drug he has touted as a “miracle.”

a person sitting on a table: Trump sparks new FDA concerns with praise of 'miracle' treatment

© Getty Images
Trump sparks new FDA concerns with praise of ‘miracle’ treatment

Doctors think the drugs show promise as a potential treatment of COVID-19, though Trump has created confusion by quickly elevating them to a cure.

“They call them therapeutic, but to me it wasn’t therapeutic,” Trump said in a video he tweeted on Wednesday, five days after receiving the experimental treatment from the biotech company Regeneron.

Trump said that he felt better immediately after taking the drugs.

“I call that a cure,” he said. “It’s a cure.”

But by placing himself in the middle of the drug evaluation process, Trump is once again igniting concerns that politics is encroaching on science at a

U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment

October 10, 2020

| No Comments

| Health

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc <AZN.L> worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

U.S. Signs Agreement With AstraZeneca to Develop, Supply COVID-19 Antibody Treatment | Top News

October 10, 2020

| No Comments

| Health

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc

worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

In a

$80M cancer treatment center proposed for Danbury clears a key hurdle

October 10, 2020

| No Comments

| Health Center

DANBURY — A proposed cancer treatment center that would use novel radiation technology to kill more tumor cells and fewer healthy tissue has cleared its first regulatory hurdle.

Proton Danbury, an $80 million facility proposed in the spring, has completed its application with a state oversight agency, clearing the way for a public hearing, a state spokesman confirmed on Thursday.

The Danbury proposal is one of two “proton therapy” cancer centers in Connecticut under review by the state Office of Health Strategy.

The other proton therapy proposal, being launched in a partnership between two of the state’s major health systems, uses the same novel technology that is being touted in Danbury as a more precise way to target cancer tumors than traditional X-ray beams, commonly called radiation.

That proposal by Hartford Health Care and Yale New Haven Health has also completed its application with the state, and is awaiting a

U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump

October 10, 2020

| No Comments

| Health News

(Reuters) – The U.S. government has awarded $486 million to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drug that was used in treating President Donald Trump.

The agreement, under the Trump administration’s Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population like those over 80 years old, the U.S. Department of Health and Human Services said.

The treatment has come under the spotlight after Trump was treated with Regeneron Pharmaceuticals’ antibody drug last week. The president has also released a video on Twitter touting its benefits.

In a call earlier on Friday, a top U.S. health official said the government was expecting to provide more than 1 million free doses of antibody treatments to COVID-19 patients, similar to the one that was administered to Trump.

Regeneron and Eli

Trump’s Regeneron Treatment Is Not a ‘Cure’

October 9, 2020

| No Comments

| Health Article

Read: Vaccine chaos is looming

First, there simply are not yet enough doses in the world. Regeneron currently has enough doses for 50,000 patients. Eli Lilly, which makes a different COVID-19 monoclonal-antibody therapy that is also in clinical trials, says it will have 100,000 doses in October. To put that in context, the United States has 50,000 new cases of COVID-19 every day.

The manufacturing of monoclonal antibodies can’t just scale up on a dime to treat everyone, says Howard Levine, who leads a group of pharmaceutical manufacturing consultants at BioProcess Technology Group. The antibodies are made inside large stainless-steel tanks using genetically engineered ovary cells from hamsters. Like all living things, they can grow only so fast. The tanks are also sophisticated pieces of equipment that can take months to install, Levine says. Regeneron and Eli Lilly have already been increasing manufacturing capacity, and they expect to have

Houston nonprofit The Rose determined to help uninsured women receive breast cancer treatment

October 9, 2020

| No Comments

| Health Article

The coronavirus pandemic has impacted millions of lives in many ways, one of which is the severe cut back in the number people keeping up with their routine checkups. Houston-based nonprofit group The Rose, which has been helping women receive breast cancer diagnoses and treatments for over 35 years regardless of their ability to pay, is determined not to give up on its mission.

Dorothy Gibbons, CEO and co-founder of The Rose, said the marked increase in the number of people putting off their mammograms was disastrous since early detection was the key to stopping cancer in most cases.

“We are conducting our screenings while observing social distancing,” said Gibbons. “We’re at 75 percent of what we normally would be doing. Some of our ladies are having to wait a bit to get their mammogram.”

The Rose operates two clinics in Houston and Bellaire respectively where women, insured or uninsured,

Donald Trump touts experimental Regeneron COVID antibody treatment

October 9, 2020

| No Comments

| Health News

In a video released on Twitter, President Trump talked up the benefits of an experimental antibody drug given to treat him for COVID.

USA TODAY

In a video released Wednesday, President Donald Trump talked up the benefits of an experimental drug that he credited for “curing” him of COVID-19. He pledged to make the therapy freely available to all Americans.

Trump received REGN-COV2, made by Regeneron, a New York biotech company, after testing positive last week for the disease. The drug, a pair of monoclonal antibodies, is intended to mimic the natural process of the immune system, providing it with molecules the body normally manufactures to fight off specific diseases.

It is currently being tested in people at various stages of the disease, including patients who have been diagnosed with COVID-19 and are symptomatic but not hospitalized, as was Trump.

It also is being considered as a prophylactic treatment

Trump’s “miracle” COVID-19 treatment was developed using cells derived from an aborted fetus: report

October 9, 2020

| No Comments

| Health

U.S. President Donald Trump leaves the White House for Walter Reed National Military Medical Center on the South Lawn of the White House on October 2, 2020 in Washington, DC. President Donald Trump and First Lady Melania Trump have both tested positive for coronavirus. Drew Angerer/Getty Images

President Donald Trump has not been shy in his praise for the experimental COVID-19 treatments he received after testing positive last week. In videos posted to Twitter, the president has falsely hailed the therapeutics as “cures” and “miracles coming down from God.”

One of the treatments made available to Trump would have been defeated by his own efforts to thwart the scientific research that made it possible: fetal cell tissue from abortions.

According to Trump’s personal physician, Dr. Sean Conley, the president received a high-dose infusion of monoclonal antibodies last Friday as part of his treatment for COVID-19 infection. Trump was

A New Study Confirms Remdesivir’s Effectiveness as a Coronavirus Treatment

October 9, 2020

| No Comments

| Health Article

Credit –

In a report published Oct. 8 in the New England Journal of Medicine, researchers confirmed the benefits of remdesivir for treating people hospitalized for COVID-19.

Remdesivir, an antiviral drug, has emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for treating anyone hospitalized for COVID-19. That authorization means that doctors can prescribe the intravenous (IV) drug for people who are infected with SARS-CoV-2 and have been hospitalized. While the drug was initially authorized only for those who needed supplemental oxygen or ventilators to breathe, an expanded EUA from the FDA in late August reflects the growing belief among doctors that treating people who aren’t as sick might provide even more benefit—so now includes people with evidence of respiratory infections but don’t yet need supplemental oxygen or help from a ventilator.

Remdesivir works by stymieing the virus’s ability to make more copies of itself, and

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Mediarabe

Tag: treatment

Trump sparks new FDA concerns with praise of ‘miracle’ treatment

U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment

U.S. Signs Agreement With AstraZeneca to Develop, Supply COVID-19 Antibody Treatment | Top News

$80M cancer treatment center proposed for Danbury clears a key hurdle

U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump

Trump’s Regeneron Treatment Is Not a ‘Cure’

Houston nonprofit The Rose determined to help uninsured women receive breast cancer treatment

Donald Trump touts experimental Regeneron COVID antibody treatment

Trump’s “miracle” COVID-19 treatment was developed using cells derived from an aborted fetus: report

A New Study Confirms Remdesivir’s Effectiveness as a Coronavirus Treatment